vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Information Services Group Inc. (III). Click either name above to swap in a different company.
Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $38.3M, roughly 1.6× ImmunityBio, Inc.). Information Services Group Inc. runs the higher net margin — 4.3% vs -161.8%, a 166.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 5.9%). Information Services Group Inc. produced more free cash flow last quarter ($4.3M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
IBRX vs III — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $61.2M |
| Net Profit | $-61.9M | $2.6M |
| Gross Margin | 99.0% | 44.8% |
| Operating Margin | -169.0% | 8.4% |
| Net Margin | -161.8% | 4.3% |
| Revenue YoY | 407.0% | 5.9% |
| Net Profit YoY | -4.7% | -14.1% |
| EPS (diluted) | $-0.06 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $61.2M | ||
| Q3 25 | $32.1M | $62.4M | ||
| Q2 25 | $26.4M | $61.6M | ||
| Q1 25 | $16.5M | $59.6M | ||
| Q4 24 | $7.6M | $57.8M | ||
| Q3 24 | $6.1M | $61.3M | ||
| Q2 24 | — | $64.3M | ||
| Q1 24 | — | $64.3M |
| Q4 25 | $-61.9M | $2.6M | ||
| Q3 25 | $-67.3M | $3.1M | ||
| Q2 25 | $-92.6M | $2.2M | ||
| Q1 25 | $-129.6M | $1.5M | ||
| Q4 24 | $-59.2M | $3.0M | ||
| Q3 24 | $-85.7M | $1.1M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $-3.4M |
| Q4 25 | 99.0% | 44.8% | ||
| Q3 25 | 99.4% | 42.2% | ||
| Q2 25 | 99.5% | 42.2% | ||
| Q1 25 | 99.6% | 43.1% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 36.1% |
| Q4 25 | -169.0% | 8.4% | ||
| Q3 25 | -173.5% | 7.4% | ||
| Q2 25 | -269.8% | 7.6% | ||
| Q1 25 | -390.1% | 5.7% | ||
| Q4 24 | -919.0% | 0.3% | ||
| Q3 24 | -1314.3% | 7.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -3.7% |
| Q4 25 | -161.8% | 4.3% | ||
| Q3 25 | -209.8% | 4.9% | ||
| Q2 25 | -350.3% | 3.5% | ||
| Q1 25 | -784.9% | 2.5% | ||
| Q4 24 | -783.4% | 5.3% | ||
| Q3 24 | -1404.0% | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | $-0.06 | $0.06 | ||
| Q3 25 | $-0.07 | $0.06 | ||
| Q2 25 | $-0.10 | $0.04 | ||
| Q1 25 | $-0.15 | $0.03 | ||
| Q4 24 | $-0.08 | $0.07 | ||
| Q3 24 | $-0.14 | $0.02 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $28.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $94.7M |
| Total Assets | $501.9M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $28.7M | ||
| Q3 25 | $257.8M | $28.7M | ||
| Q2 25 | $153.7M | $25.2M | ||
| Q1 25 | $61.6M | $20.1M | ||
| Q4 24 | $149.8M | $23.1M | ||
| Q3 24 | $130.4M | $9.7M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $14.0M |
| Q4 25 | $-500.5M | $94.7M | ||
| Q3 25 | $-524.3M | $94.7M | ||
| Q2 25 | $-570.7M | $94.1M | ||
| Q1 25 | $-591.4M | $95.0M | ||
| Q4 24 | $-489.1M | $96.3M | ||
| Q3 24 | $-745.1M | $96.6M | ||
| Q2 24 | — | $95.5M | ||
| Q1 24 | — | $95.6M |
| Q4 25 | $501.9M | $211.0M | ||
| Q3 25 | $519.0M | $213.3M | ||
| Q2 25 | $402.1M | $200.7M | ||
| Q1 25 | $303.8M | $202.4M | ||
| Q4 24 | $382.9M | $204.5M | ||
| Q3 24 | $364.6M | $227.1M | ||
| Q2 24 | — | $235.3M | ||
| Q1 24 | — | $234.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $5.1M |
| Free Cash FlowOCF − Capex | $-71.3M | $4.3M |
| FCF MarginFCF / Revenue | -186.2% | 7.0% |
| Capex IntensityCapex / Revenue | 2.4% | 1.2% |
| Cash ConversionOCF / Net Profit | — | 1.94× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $5.1M | ||
| Q3 25 | $-68.9M | $11.1M | ||
| Q2 25 | $-79.7M | $11.9M | ||
| Q1 25 | $-85.9M | $978.0K | ||
| Q4 24 | $-85.1M | $6.6M | ||
| Q3 24 | $-98.8M | $8.8M | ||
| Q2 24 | — | $2.2M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | $-71.3M | $4.3M | ||
| Q3 25 | $-69.6M | $9.5M | ||
| Q2 25 | $-80.8M | $11.1M | ||
| Q1 25 | $-87.0M | $141.0K | ||
| Q4 24 | $-87.3M | $6.0M | ||
| Q3 24 | $-101.6M | $8.4M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | -186.2% | 7.0% | ||
| Q3 25 | -217.2% | 15.2% | ||
| Q2 25 | -305.9% | 18.0% | ||
| Q1 25 | -526.9% | 0.2% | ||
| Q4 24 | -1155.4% | 10.4% | ||
| Q3 24 | -1663.2% | 13.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | 2.4% | 1.2% | ||
| Q3 25 | 2.3% | 2.5% | ||
| Q2 25 | 4.1% | 1.4% | ||
| Q1 25 | 6.8% | 1.4% | ||
| Q4 24 | 28.0% | 0.9% | ||
| Q3 24 | 45.7% | 0.6% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 1.94× | ||
| Q3 25 | — | 3.62× | ||
| Q2 25 | — | 5.46× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 2.15× | ||
| Q3 24 | — | 7.66× | ||
| Q2 24 | — | 1.07× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
